Negative pressure wound therapy (NPWT) — marketed most widely under the KCI V.A.C. brand — is one of the more technically demanding wound care modalities a nurse will manage. You will encounter it on surgical floors, in the ICU, in wound care clinics, and in home health. Nursing students often find NPWT intimidating because it combines hands-on dressing technique with device management and critical assessment skills. This guide breaks it all down: how the therapy works, when it is and is not appropriate, how to change the dressing step by step, what to assess at every change, and how to handle the alarms and complications that show up most often on the NCLEX.
Quick-reference overview
| Parameter | Details |
|---|---|
| Mechanism | Subatmospheric (negative) pressure applied to the wound bed via sealed foam dressing and suction tubing connected to a canister |
| Pressure range | –75 to –125 mmHg (typical); –75 mmHg for grafts/flaps; –125 mmHg for chronic wounds |
| Modes | Continuous (standard) or intermittent (used for wound contraction, better tolerated in some patients) |
| Foam types | Black polyurethane (standard) or white PVA (tunneling wounds, fragile tissue, proximity to vessels/nerves) |
| Dressing change frequency | Every 48–72 hours; more frequently if wound is infected or heavily exudating; never exceed 72 hours |
| Key indications | Chronic wounds (diabetic foot ulcers, venous stasis ulcers), Stage 3/4 pressure injuries, dehisced surgical wounds, open abdominal wounds, skin grafts, traumatic wounds |
| Absolute contraindications | Malignancy in the wound, untreated osteomyelitis, exposed vessels/nerves/organs, necrotic tissue with eschar (debride first), fistulas communicating with organs or body cavities |
| Canister change | When full or every 3–5 days; bloody or foul-smelling drainage → notify provider |
How NPWT works
NPWT applies subatmospheric pressure — pressure below atmospheric baseline — to the wound environment through a sealed foam dressing connected to a suction device and collection canister. The mechanism produces four simultaneous therapeutic effects:
- Mechanical wound closure. Negative pressure draws wound edges toward the center, physically reducing wound dimensions over time.
- Exudate removal. Excess fluid, inflammatory mediators, and bacteria are continuously evacuated from the wound bed into the canister, reducing the bacterial load and bioburden.
- Edema reduction. Removing interstitial fluid decreases periwound edema, which improves local perfusion and oxygen delivery to healing tissue.
- Granulation tissue stimulation. The microdeformational forces created by the foam against the wound bed activate fibroblast migration and angiogenesis, accelerating the growth of healthy granulation tissue.
Pressure settings
The standard therapeutic range is –75 to –125 mmHg. The exact setting depends on wound type and patient tolerance:
- –75 mmHg: Used for skin grafts and flaps, where higher suction could disrupt the graft-to-bed interface and impair take. Also used when patients cannot tolerate higher pressures.
- –125 mmHg: The default for most chronic wounds and surgical dehiscence. Provides more aggressive exudate removal and granulation stimulation.
Continuous vs. intermittent mode
Continuous mode maintains steady negative pressure and is the standard approach. It is better tolerated for most patients and used as first-line.
Intermittent mode cycles between negative pressure and atmospheric pressure at set intervals. It generates stronger macrostrain forces during the pressure-off phases and may enhance wound contraction in select cases, but it is less comfortable and not appropriate for all wound types. Providers specify the mode in the order.
Indications and contraindications
Getting indications and contraindications right is a persistent NCLEX challenge. The question will often present a clinical scenario and ask whether NPWT is appropriate — the correct answer almost always hinges on one of the absolute contraindications.
| Category | Indications | Contraindications |
|---|---|---|
| Wound type | Chronic wounds (venous stasis ulcers, diabetic foot ulcers); Stage 3/4 pressure injuries; dehisced surgical wounds; open abdominal wounds; traumatic wounds | Wounds with malignancy; necrotic tissue or eschar present (debride first — NPWT cannot substitute for debridement) |
| Surgical/reconstructive | Skin grafts (secure graft-to-bed contact, reduce shear); flap coverage; sternal wound dehiscence; burn wounds when grafted | Exposed blood vessels, nerves, or organs in the wound base — direct foam contact can erode tissue or cause hemorrhage |
| Infection status | Wounds with controlled, treated infection — NPWT is not a substitute for antibiotics, but it can adjunct treatment of an actively managed wound | Untreated osteomyelitis — bone infection must be treated systemically before NPWT application; see osteomyelitis nursing for further context |
| Fistulas | Enteric fistulas in select cases (only when the fistula is identified, controlled, and the provider has specifically ordered NPWT with that anatomy in mind) | Non-enteric fistulas; unexplored fistulas communicating with organs or body cavities — suction can pull bowel content into the wound or create catastrophic negative pressure effects on organs |
| Bleeding risk | Wounds where hemostasis is confirmed and stable | Active bleeding, patients on anticoagulants with uncontrolled coagulopathy — use with extreme caution; any fresh bright-red blood in canister requires immediate device cessation and provider notification |
The clinical principle for NCLEX: NPWT augments healing — it does not treat infection, remove necrosis, or replace surgical management. Every contraindication stems from a scenario where applying negative pressure would either worsen the underlying problem or create a new dangerous one.
Foam selection: black vs. white
Foam choice is a clinically significant decision, not a preference. The two options have different structural properties that produce different effects on the wound bed.
Black polyurethane foam (GranuFoam) This is the standard foam used in most NPWT applications. Its open-cell pore structure transmits negative pressure evenly across the wound surface, generates microdeformational forces that stimulate granulation tissue, and handles high exudate volumes well. Use black foam for: chronic wounds, pressure injuries, dehisced wounds, traumatic wounds, and any wound where aggressive granulation promotion is the goal.
White polyvinyl alcohol (PVA) foam (WhiteFoam) White foam is denser with smaller pore sizes. It transmits negative pressure but produces less aggressive tissue deformation, which makes it the choice when the wound bed is fragile or when anatomical structures create risk. Use white foam for:
- Tunneling wounds (where foam needs to be inserted into a tract without damaging tissue walls)
- Wounds with exposed or at-risk vessels, nerves, or tendons
- Wounds where granulation tissue is already well-established and protection is more important than stimulation
- Patients with pain sensitivity where less tissue disruption is clinically indicated
NCLEX tip: If a question describes a wound near an exposed tendon or asks about tunneling, white foam is the correct choice. If a question asks about a chronic diabetic ulcer needing granulation, black foam is correct.
Dressing change procedure
NPWT dressing changes require more preparation and technique than standard dressing changes. Pre-medicate the patient 30 minutes before starting (discussed in the pain management section). Gather all supplies before entering the room — interrupted setup wastes time and increases infection risk. This procedure aligns with current sterile technique nursing principles.
Supplies needed: PPE (gloves, gown, mask if indicated), new foam of correct type, transparent occlusive draping (NPWT-specific), wound irrigation solution if ordered, skin barrier/prep (for periwound protection), tubing and new canister if needed, measuring device (ruler or wound measuring guide), wound assessment documentation tool.
Step-by-step procedure
-
Verify the order. Confirm foam type, pressure setting, mode (continuous vs. intermittent), and change frequency in the provider orders before touching the patient.
-
Perform hand hygiene and apply PPE. Wound VAC dressings carry significant exudate and infection risk. Gown up appropriately.
-
Turn off the device. Press the power button or therapy button to stop suction before attempting foam removal. Removing foam while suction is active causes significant patient pain and can traumatize granulation tissue.
-
Clamp the tubing. Clamp the tubing close to the dressing before disconnecting. This prevents air entry and minimizes exudate spill.
-
Remove the occlusive drape. Peel back the drape slowly from the edges toward the center. If the drape has adhered firmly to the periwound skin, apply gentle traction and use skin-safe adhesive remover if available. Rushed drape removal causes medical adhesive-related skin injury (MARSI) — a preventable complication.
-
Remove the foam. Foam frequently adheres to the wound bed, especially after the full 72-hour wear time. Soak the foam with normal saline and allow 1–2 minutes of contact time before attempting removal. This softens the foam-tissue interface and significantly reduces pain and trauma. Remove the foam gently — never forcefully pull adherent foam from a wound. Count all foam pieces removed. The piece count must match the number placed at the prior change.
-
Assess the wound. This is a critical nursing responsibility (detailed in the next section). Document wound dimensions, tissue type, drainage, periwound condition, and wound edges before placing the new dressing.
-
Irrigate if ordered. Use the prescribed solution (typically normal saline). Deliver at appropriate pressure (8–15 psi for most wounds — a 35 mL syringe with a 19-gauge angiocatheter delivers approximately this pressure). Gently pat dry with gauze.
-
Apply skin barrier to periwound skin. Skin prep/barrier wipes applied 3–5 cm beyond the wound margin protect periwound skin from MARSI and maceration from the occlusive drape adhesive. Allow it to dry completely before draping.
-
Cut foam to wound dimensions. Cut the foam to fit the wound bed with contact on all wound surfaces. Do not cut the foam smaller than the wound (leaves unprotected wound surface) or pack it tightly (increases pressure at the packing point and can cause pressure injury to wound edges). The foam should contact the wound bed — not be compressed into it.
-
Place the foam. For tunneling wounds using white foam, gently insert the foam into the tunnel. Document how many pieces are placed.
-
Cover with occlusive draping. Apply the transparent drape to overlap 3–5 cm beyond the foam margin onto intact periwound skin on all sides. Press down firmly to ensure an airtight seal. Pay close attention to skin folds, bony prominences, and irregular anatomy — these are where leaks occur.
-
Attach the tubing and canister. Connect the NPWT-specific tubing to the drape port, then connect to the canister and device.
-
Activate the device and verify the seal. Turn therapy on. Within 30–60 seconds, the foam should visibly collapse and shrink — this confirms the seal is intact and negative pressure is being achieved. If the foam does not collapse, an air leak is present.
Seal verification: If foam does not collapse, systematically check: (1) all drape edges; (2) where tubing exits the drape; (3) any bridges placed over bony prominences or skin folds; (4) proximity to ostomies or drain sites. Re-reinforce leaking edges with additional drape material.
Wound assessment at dressing changes
Every NPWT dressing change is a structured assessment opportunity. This is where you identify whether the therapy is working, whether complications are developing, and whether the wound plan needs to change. This assessment integrates with the principles described in wound assessment.
Dimensions: Measure length × width × depth at every change using a standardized technique (greatest length, greatest width perpendicular to length, greatest depth). Wound dimensions should be decreasing over the course of NPWT — a wound that is not contracting after 2–4 weeks warrants provider reassessment of the therapy plan.
Tissue type: Document the percentage of the wound base covered by each tissue type:
- Granulation tissue (beefy red, moist, bumpy) — the target tissue. Should increase over time.
- Slough (yellow/tan, soft, stringy) — non-viable tissue. Should decrease with effective NPWT.
- Eschar (black/brown, hard) — should not be present when NPWT is initiated. If eschar develops or was missed at initiation, notify the provider — NPWT is contraindicated until debridement occurs.
- Epithelial tissue (pale pink, fragile edges migrating inward) — a sign of advanced healing, typically seen as the wound approaches closure.
Drainage characteristics: Document color, consistency, volume (estimated), and odor. Sanguineous (bloody) drainage is expected for the first 24–48 hours after placement or changes but should transition to serosanguineous and then serous as healing progresses. Purulent drainage, foul odor, or significant increases in drainage volume warrant provider notification and reassessment for wound infection — see infection control nursing for assessment principles.
Periwound skin: Assess for maceration (softening, white discoloration), MARSI (erythema, blistering, skin stripping at drape margins), and signs of spreading infection (erythema, warmth, induration extending beyond the wound edge). These findings require immediate intervention and provider notification.
Wound edges: Edges should be progressively advancing toward the wound center. Rolled, hyperkeratotic, or epibolic edges suggest the wound has stalled and may need debridement.
Canister management and alarm troubleshooting
| Alarm / finding | Likely cause | Nursing action |
|---|---|---|
| Low pressure / leak alarm | Air leak in the occlusive seal — most common cause; also occurs with disconnected tubing or cracked canister | Systematically check drape edges, tubing connections, and canister integrity. Re-reinforce leaking areas with additional draping. If leak cannot be resolved, perform a full dressing change. |
| Full canister alarm | Canister has reached capacity | Stop therapy, clamp tubing, disconnect and discard full canister, connect new canister, resume therapy. Document exudate volume from full canister. Change canister every 3–5 days regardless of fill level. |
| Blocked tube alarm | Tubing kinked, clotted with exudate, or compressed under patient | Trace full length of tubing and remove any kinks or compression. If clotted, gently milk the tubing toward the canister. Persistent blockage may require tubing replacement. |
| Foam not collapsing after activation | Air leak in drape (see above) | Same as low pressure alarm. Foam collapse is the primary visual confirmation that negative pressure is being delivered to the wound bed. |
| Bloody/sanguineous drainage in canister | Active bleeding from wound bed — can indicate vessel erosion, trauma from dressing removal, or underlying coagulopathy | Stop therapy immediately. Apply pressure if active bleeding. Notify provider emergently. Do not restart therapy until provider evaluates. Document time, drainage volume and appearance, and all actions taken. |
| Foul-smelling or purulent canister drainage | Wound infection or significant increase in bioburden | Do not restart therapy until the wound is assessed. Notify provider. Collect wound culture if ordered. Document drainage characteristics thoroughly. |
| Patient reports severe pain | Pressure setting too high; foam adhering to wound; incorrect foam type; device malfunction | Stop therapy and assess. Pre-medicate before next change. Notify provider if pain is out of proportion — may indicate foam is contacting a vessel or nerve. Use pain assessment tools per pain assessment nursing guidelines. |
Pain management
NPWT is one of the more uncomfortable wound care interventions, and the dressing change itself is typically the most painful part. Adherent foam pulling away from granulation tissue generates significant nociceptive pain. Inadequate analgesia is one of the most common reasons patients refuse or delay NPWT dressing changes — delays that then increase infection risk and worsen outcomes.
Pre-medication protocol: Administer prescribed analgesics 30 minutes before starting the dressing change. For patients on scheduled opioids, time the dressing change to coincide with the peak effect window. For patients using oral analgesics only, coordinate timing with the pharmacy and nursing schedule.
Foam soaking technique: Before removing foam, flood the wound site with normal saline and allow 1–2 minutes of soak time. The saline dissolves the protein bonds between foam and granulation tissue. This is the most impactful single technique for reducing procedural pain at dressing changes. Do not rush this step.
Non-pharmacological adjuncts: Positioning the patient to minimize tension on the wound region, providing distraction (music, conversation), and coaching the patient through slow breathing during the most uncomfortable removal phase all contribute to procedural comfort.
Ongoing assessment: Use a validated pain scale (pain assessment nursing) at every dressing change, both before pre-medication and after the procedure. If pain is consistently poorly controlled, notify the provider — the pressure setting may need adjustment downward or the foam type may need to change.
Patient education
Many NPWT patients are discharged home with their device. Effective discharge teaching nursing is essential for safety and therapy compliance. Home health nurses will reinforce these points on each visit, but the inpatient nurse who first educates the patient sets the foundation.
Device portability: Modern NPWT devices are compact and battery-powered. Ambulatory patients can carry the device with them. Demonstrate how to manage the tubing and carry the device without kinking the tubing. The device does not need to be stationary.
Bathing and hygiene: The patient must not shower or submerge the wound while the NPWT device is connected. Sponge bathing around the dressing is appropriate. If the patient has a removable device for hygiene, this should be explicitly ordered and timed — the dressing must remain intact and the device reconnected promptly.
Alarm response: Teach the patient to recognize the three common alarms (leak, full canister, blocked tube) and know that an alarm does not mean the wound is harmed. For home patients: check tubing, check drape edges, call the home health nurse or outpatient wound clinic if the alarm cannot be silenced. Never manipulate pressure settings.
Activity restrictions and wound protection: No pressure or weight-bearing directly on the wound site unless specifically cleared by the provider. Protect the device from extreme temperatures. Sleep positioning should avoid lying on the device or tubing.
When to call for help: Any of the following require an immediate call: bright red blood in the tubing or canister, new severe pain, fever, worsening odor, or an alarm that will not clear.
NCLEX tips
- NPWT applies subatmospheric pressure — pressure below atmospheric — to the wound bed, typically –75 to –125 mmHg.
- The KCI V.A.C. (Vacuum Assisted Closure) system is the most common brand name; the generic clinical term is NPWT (Negative Pressure Wound Therapy).
- NPWT promotes wound healing through four mechanisms: mechanical wound closure, exudate removal, edema reduction, and granulation tissue stimulation.
- Absolute contraindication #1 — malignancy in the wound. Never apply NPWT to a wound that contains or is suspected to contain cancerous tissue.
- Absolute contraindication #2 — untreated osteomyelitis. Treat the bone infection first; NPWT is not appropriate until systemic treatment is established.
- Absolute contraindication #3 — necrotic tissue/eschar. Debride first. NPWT does not remove necrosis — it requires a clean wound bed to be effective.
- Absolute contraindication #4 — exposed vessels, nerves, or organs. Direct foam contact with these structures risks erosion and catastrophic hemorrhage.
- Black polyurethane foam = standard choice for most wounds (promotes granulation tissue).
- White PVA foam = tunneling wounds, fragile tissue, wounds near vessels or nerves (less aggressive deformation).
- Dressing changes every 48–72 hours is the standard; never leave in place beyond 72 hours due to infection risk.
- For skin grafts and flaps, use a lower pressure setting (–75 mmHg) to avoid disrupting graft-to-bed interface.
- Foam must be cut to wound shape and placed with contact — not tightly packed. Tight packing creates pressure points at wound edges.
- The occlusive drape must overlap 3–5 cm beyond the foam margin onto intact periwound skin for an adequate seal.
- Foam collapse after device activation is visual confirmation of an intact seal and effective negative pressure delivery.
- Bloody drainage in the canister = stop therapy immediately and notify the provider. This is a high-acuity finding.
- Pre-medicate 30 minutes before dressing changes and soak foam with normal saline before removal to reduce procedural pain.
- Canister should be changed when full or every 3–5 days. Document volume, color, and consistency of drainage at each change.
- A low-pressure alarm almost always means an air leak — check drape edges, tubing connections, and skin folds.
- Wound dimensions (L × W × D) should decrease over time with effective NPWT. A wound that is not contracting after 2–4 weeks warrants reassessment.
- NPWT does not treat infection — it can be used alongside antibiotic therapy for managed infections, but infection must be under active treatment first.
NCLEX practice scenarios
| Clinical scenario | Correct answer | Rationale |
|---|---|---|
| A nurse is preparing to apply NPWT to a patient with a Stage 4 pressure injury. The wound base contains 40% black eschar. What is the priority action? | Notify the provider and hold NPWT until debridement is performed | Necrotic tissue/eschar is an absolute contraindication to NPWT. The wound must be debrided before therapy is initiated. Placing NPWT on a wound with eschar does not remove the necrosis and delays appropriate wound bed preparation. |
| A patient with a dehisced abdominal wound has NPWT in place. The nurse activates the device and observes that the foam does not collapse. What is the next action? | Check the occlusive drape for air leaks and reinforce edges | Foam collapse is the visual confirmation that negative pressure is being achieved. If the foam does not collapse, an air leak is present — most commonly at drape edges, skin folds, or the tubing exit site. Systematically check and reinforce before escalating. |
| A nurse is changing the NPWT dressing of a patient with a large sacral pressure injury. Which foam should be selected for the tunneling tract within the wound? | White PVA foam | White foam is the correct choice for tunneling wounds. Its denser, smaller-pore structure is appropriate for inserting into wound tracts without causing traumatic deformation of the tract walls. Black foam is too aggressive for tunneling applications. |
| A patient receiving NPWT for a skin graft on the right lower leg. The provider has not specified a pressure setting. The nurse anticipates which setting will be ordered? | –75 mmHg | Lower pressure (–75 mmHg) is used for skin grafts and flaps to maintain secure graft-to-bed contact without disrupting the newly placed graft. Higher pressures (–125 mmHg) are reserved for chronic wounds where aggressive exudate removal and granulation stimulation are needed. |
| While reviewing NPWT orders for a new patient, the nurse notes the wound was caused by a squamous cell carcinoma that has not yet been surgically excised. What is the correct action? | Do not apply NPWT; notify the provider | Malignancy in the wound is an absolute contraindication to NPWT. Applying negative pressure to a malignant wound is contraindicated and potentially harmful. The nurse must verify the order and communicate the concern to the provider before proceeding. |
| A patient who has been receiving NPWT for 5 days reports severe, unrelenting pain during the dressing change despite having received oral analgesics 20 minutes prior. The nurse observes bright red bleeding from the wound base. What is the priority action? | Stop therapy immediately, apply gentle pressure, and notify the provider emergently | Bright red sanguineous bleeding from the wound base during NPWT represents a potential vessel erosion emergency. Therapy must be stopped immediately to prevent continued hemorrhage. This is a high-priority finding requiring emergent provider notification and clinical evaluation. |
| A nurse enters a patient's room and finds the NPWT device alarming with a "blocked tube" alarm. What is the correct first action? | Trace the full length of tubing to identify and correct any kinks or compression | Tube blockage alarms most commonly result from kinked or compressed tubing — for example, a patient lying on the tubing. Tracing and correcting the tubing is the appropriate first step before assuming internal clotting or device malfunction. |
| A patient with a chronic venous stasis ulcer is being discharged home with a portable NPWT device. Which patient statement indicates correct understanding of discharge instructions? | "I should not shower with the device attached. I will sponge bathe around the dressing instead." | The NPWT dressing and device must not be submerged or exposed to shower water. Sponge bathing is appropriate. Showering with the device would compromise the occlusive seal and risk contaminating the wound. |
| During NPWT dressing removal, the foam is firmly adhered to the wound bed. The patient grimaces in pain. What is the correct technique to facilitate foam removal? | Soak the foam with normal saline and wait 1–2 minutes before attempting removal | Soaking adherent foam with saline dissolves the protein bonds between the foam and wound bed tissue, significantly reducing both the force required for removal and the resulting pain. Pulling forcefully on adherent foam traumatizes granulation tissue. |
| A nurse is placing NPWT on a patient with a large abdominal wound that includes a known enteroatmospheric fistula. The provider has specifically ordered NPWT with the fistula anatomy documented. What is the correct nursing action? | Proceed with NPWT as ordered, using appropriate foam bridging to isolate fistula output from the suction field | Known, identified enteric fistulas are not an absolute contraindication when the provider has specifically ordered NPWT with awareness of the anatomy and has a plan for fistula management. The contraindication applies to unexplored or non-enteric fistulas communicating with body cavities. |
| A nurse completes an NPWT dressing change for a patient with a diabetic foot wound. Wound measurements today are length 4.2 cm, width 3.0 cm, depth 1.1 cm compared to last week's measurements of 5.8 cm × 3.9 cm × 1.6 cm. How should the nurse interpret this finding? | The wound is responding to NPWT — dimensions have decreased, indicating wound contraction and healing progress | Decreasing wound dimensions across all planes (length, width, depth) indicate that NPWT is achieving its primary goal of wound contraction. This is an expected and desired outcome. Stable or increasing dimensions after 2–4 weeks would prompt reassessment. |
| A patient with a large traumatic wound on the right thigh is receiving NPWT. The nurse notes the canister drainage has changed from serosanguineous to bright red over the past two hours. What is the priority action? | Stop therapy immediately and notify the provider | A change from serosanguineous to frank sanguineous drainage in the canister indicates acute bleeding — a potentially serious complication of NPWT that may represent vessel erosion or a coagulopathy event. This requires immediate cessation of therapy and emergent provider notification, not continued monitoring. |
Related skills
- Wound care nursing — foundational dressing selection, wound bed preparation, and moist wound healing principles that underpin NPWT decisions
- Pressure injury nursing — Stage 3 and 4 pressure injuries are among the most common indications for NPWT; staging and management context
- Wound assessment — systematic wound measurement and documentation, which is performed at every NPWT dressing change
- Infection control nursing — PPE selection, standard precautions, and recognizing wound infection — all relevant to safe NPWT management
- Sterile technique nursing — principles of aseptic technique applied during NPWT dressing changes
- Pain assessment nursing — validated pain tools and assessment principles used to manage procedural pain at NPWT changes
- Discharge teaching nursing — structured patient education framework for home NPWT management
- Osteomyelitis nursing — osteomyelitis is a contraindication to NPWT until treated; understanding the relationship between bone infection and wound management is clinically important